Two separate teams of researchers have discovered yet another way in which gut bacteria influence the health of their hosts. In mice, such bacteria played a role in the response to three separate types of cancer therapy. Germ-free mice or those treated with antibiotics had weaker responses to an experimental immunotherapy, platinum chemotherapy and cyclophosphamide, which both promotes immunogenic cell death and affects the balance of different T-cell types.